Trial Profile
The Antiviral Efficacy of Entecavir in Chronic Hepatitis B Within the European Network of Excellence (VIRGIL)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2022
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms VIRGIL
- 24 Mar 2016 Results (outcome of ALT flares, n=729) published in the Journal of Gastroenterology and Hepatology.
- 30 Mar 2011 New trial record